Quick Answer
Glucose Health, Inc. reported Cash and Equivalents of $20.5 thousand for fiscal year 2016.
Glucose Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2016 | $20.5K | +899.6% |
| 2015 | $2.1K | -57.8% |
| 2014 | $4.9K | +585.1% |
| 2013 | $711.00 | -33.9% |
| 2012 | $1.1K | +1212.2% |
| 2011 | $82.00 | -97.9% |
| 2011 | $3.9K | +11806.1% |
| 2010 | $33.00 | +725.0% |
| 2009 | $4.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | $16.6K | — | -9.2% |
| June 30, 2017 | $18.3K | — | +103.3% |
| March 31, 2017 | $9.0K | — | -56.1% |
| December 31, 2016 | $20.5K | +899.6% | +899.6% |
| December 31, 2015 | $2.1K | -57.8% | -57.8% |
| December 31, 2014 | $4.9K | +585.1% | +585.1% |
| December 31, 2013 | $711.00 | -33.9% | -33.9% |
| December 31, 2012 | $1.1K | +1212.2% | -92.8% |
- Glucose Health, Inc. showed an increase of +899.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2016 period, Glucose Health, Inc.’s cash and equivalents has grown by 513450.0% (from $4.00 to $20.5 thousand).
- The most recent figure is from Glucose Health, Inc.’s fiscal year 2016 report (Form 10-K), filed with the SEC on March 29, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: